The Prostate Cancer Foundation position: PSA screening remains a valuable tool

The Prostate Cancer Foundation (PCF) reiterated its position that PSA screening remains a valuable tool, in combination with other tools, for identifying potential prostate disease, including cancer. They did that in responding to continued debate over PSA screening, and today’s American Cancer Society statement. PCF is also calling for more reasoned debate that empowers patients and their physicians and improves patients’ understanding of PSA data, prostate cancer and treatment options. According to Prostate Cancer Foundation, every man has the right to know if he has cancer and to make informed decisions with his urologist. This right dialog between patients, family members and urologists requires to be based on the pros and cons of screening and treatment options. [ continue reading ]